Cargando…
Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head
Glucocorticoids inhibit angiogenesis in the femoral head, which fails to nourish the bone tissue and leads to osteonecrosis. Restoring angiogenesis is not only essential for vessel formation, but also crucial for osteogenesis. Poly ((L)-lactic acid) (PLLA) is commonly used in the bone tissue enginee...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863477/ https://www.ncbi.nlm.nih.gov/pubmed/36662078 http://dx.doi.org/10.3390/jfb14010031 |
_version_ | 1784875344052879360 |
---|---|
author | Feng, Guiyu Zhang, Pingxin Huang, Jian Yu, Yao Yang, Fenghe Zhao, Xueqian Wang, Wei Li, Dongyang Sun, Song Niu, Xufeng Chai, Limin Li, Jinyu |
author_facet | Feng, Guiyu Zhang, Pingxin Huang, Jian Yu, Yao Yang, Fenghe Zhao, Xueqian Wang, Wei Li, Dongyang Sun, Song Niu, Xufeng Chai, Limin Li, Jinyu |
author_sort | Feng, Guiyu |
collection | PubMed |
description | Glucocorticoids inhibit angiogenesis in the femoral head, which fails to nourish the bone tissue and leads to osteonecrosis. Restoring angiogenesis is not only essential for vessel formation, but also crucial for osteogenesis. Poly ((L)-lactic acid) (PLLA) is commonly used in the bone tissue engineering field. Panax notoginseng saponins (PNS) and osteopractic total flavone (OTF) promote angiogenesis and osteogenesis, respectively. We designed a sequentially releasing PLLA scaffold including PLLA loaded with OTF (inner layer) and PLLA loaded with PNS (outer layer). We assessed the osteogenic effect of angiogenesis in this scaffold by comparing it with the one-layered scaffold (PLLA embedded with OTF and PNS) in vivo. Results from the micro-CT showed that the data of bone mineral density (BMD), bone volume (BV), and percent bone volume (BV/TV) in the PO-PP group were significantly higher than those in the POP group (p < 0.01). Histological analyses show that the PO-PP scaffold exhibits better angiogenic and osteogenic effects compared with the one-layered scaffold. These might result from the different structures between them, where the sequential release of a bi-layer scaffold achieves the osteogenic effect of vascularization by initially releasing PNS in the outer layer. We further explored the possible mechanism by an immunohistochemistry analysis and an immunofluorescence assay. The results showed that the protein expressions of vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule-1(CD31) in the PO-PP scaffold were significantly higher than those in the POP scaffold (p < 0.01); the protein expressions of osteocalcin (OCN), osteopontin (OPN), and alkaline phosphatase (ALP) in the PO-PP scaffold were significantly higher than those in the POP scaffold (p < 0.05). Upregulating the expressions of angiogenic and osteogenic proteins might be the possible mechanism. |
format | Online Article Text |
id | pubmed-9863477 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98634772023-01-22 Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head Feng, Guiyu Zhang, Pingxin Huang, Jian Yu, Yao Yang, Fenghe Zhao, Xueqian Wang, Wei Li, Dongyang Sun, Song Niu, Xufeng Chai, Limin Li, Jinyu J Funct Biomater Article Glucocorticoids inhibit angiogenesis in the femoral head, which fails to nourish the bone tissue and leads to osteonecrosis. Restoring angiogenesis is not only essential for vessel formation, but also crucial for osteogenesis. Poly ((L)-lactic acid) (PLLA) is commonly used in the bone tissue engineering field. Panax notoginseng saponins (PNS) and osteopractic total flavone (OTF) promote angiogenesis and osteogenesis, respectively. We designed a sequentially releasing PLLA scaffold including PLLA loaded with OTF (inner layer) and PLLA loaded with PNS (outer layer). We assessed the osteogenic effect of angiogenesis in this scaffold by comparing it with the one-layered scaffold (PLLA embedded with OTF and PNS) in vivo. Results from the micro-CT showed that the data of bone mineral density (BMD), bone volume (BV), and percent bone volume (BV/TV) in the PO-PP group were significantly higher than those in the POP group (p < 0.01). Histological analyses show that the PO-PP scaffold exhibits better angiogenic and osteogenic effects compared with the one-layered scaffold. These might result from the different structures between them, where the sequential release of a bi-layer scaffold achieves the osteogenic effect of vascularization by initially releasing PNS in the outer layer. We further explored the possible mechanism by an immunohistochemistry analysis and an immunofluorescence assay. The results showed that the protein expressions of vascular endothelial growth factor (VEGF) and platelet endothelial cell adhesion molecule-1(CD31) in the PO-PP scaffold were significantly higher than those in the POP scaffold (p < 0.01); the protein expressions of osteocalcin (OCN), osteopontin (OPN), and alkaline phosphatase (ALP) in the PO-PP scaffold were significantly higher than those in the POP scaffold (p < 0.05). Upregulating the expressions of angiogenic and osteogenic proteins might be the possible mechanism. MDPI 2023-01-04 /pmc/articles/PMC9863477/ /pubmed/36662078 http://dx.doi.org/10.3390/jfb14010031 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Feng, Guiyu Zhang, Pingxin Huang, Jian Yu, Yao Yang, Fenghe Zhao, Xueqian Wang, Wei Li, Dongyang Sun, Song Niu, Xufeng Chai, Limin Li, Jinyu Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head |
title | Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head |
title_full | Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head |
title_fullStr | Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head |
title_full_unstemmed | Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head |
title_short | Sequential Release of Panax Notoginseng Saponins and Osteopractic Total Flavone from Poly ((L)-Lactic Acid) Scaffold for Treating Glucocorticoid-Associated Osteonecrosis of Femoral Head |
title_sort | sequential release of panax notoginseng saponins and osteopractic total flavone from poly ((l)-lactic acid) scaffold for treating glucocorticoid-associated osteonecrosis of femoral head |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863477/ https://www.ncbi.nlm.nih.gov/pubmed/36662078 http://dx.doi.org/10.3390/jfb14010031 |
work_keys_str_mv | AT fengguiyu sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT zhangpingxin sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT huangjian sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT yuyao sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT yangfenghe sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT zhaoxueqian sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT wangwei sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT lidongyang sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT sunsong sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT niuxufeng sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT chailimin sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead AT lijinyu sequentialreleaseofpanaxnotoginsengsaponinsandosteopractictotalflavonefrompolyllacticacidscaffoldfortreatingglucocorticoidassociatedosteonecrosisoffemoralhead |